|
FAM111B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.8746783559418E-14 |
| Normal-vs-Stage2 |
1.033500E-02 |
| Normal-vs-Stage3 |
3.5544000000054E-05 |
| Normal-vs-Stage4 |
1.306180E-02 |
| Stage1-vs-Stage2 |
5.000800E-01 |
| Stage1-vs-Stage3 |
3.775100E-03 |
| Stage1-vs-Stage4 |
1.237360E-01 |
| Stage2-vs-Stage3 |
6.178300E-02 |
| Stage2-vs-Stage4 |
2.661800E-01 |
| Stage3-vs-Stage4 |
6.143000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.35979999879876E-08 |
| Normal-vs-Asian |
1.510020E-02 |
| Caucasian-vs-AfricanAmerican |
9.196200E-01 |
| Caucasian-vs-Asian |
6.943400E-01 |
| AfricanAmerican-vs-Asian |
6.228800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.13340004048723E-09 |
| Male-vs-Female |
6.659500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.16579999998034E-06 |
| Normal-vs-Extreme_Weight |
1.99830041403004E-10 |
| Normal-vs-Obese |
2.14300000001E-06 |
| Normal-vs-Extreme_Obese |
8.840500E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.860200E-02 |
| Normal_Weight-vs-Obese |
5.175000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.195500E-03 |
| Extreme_Weight-vs-Obese |
3.692300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.171500E-02 |
| Obese-vs-Extreme_Obese |
2.839200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.382000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.30926389122033E-14 |
| Normal-vs-Age(61-80Yrs) |
3.54460905072074E-12 |
| Normal-vs-Age(81-100Yrs) |
1.667580E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.438220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.371900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.320000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.014180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.010200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.254400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
5.66290003778391E-09 |
| Normal-VS-KIRP CIMP |
3.237400E-03 |
| Normal-VS-Unclassified PRCC |
9.18470000055294E-08 |
| Type1 PRCC-VS-Type2 PRCC |
5.536300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.843900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.904400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.504180E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.257600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.163890E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.19279999999789E-07 |
| Normal-vs-N1 |
4.1763000000028E-05 |
| Normal-vs-N2 |
1.207020E-01 |
| N0-vs-N1 |
2.524200E-03 |
| N0-vs-N2 |
9.842600E-01 |
| N1-vs-N2 |
1.799640E-01 |
|
|
